Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

13.90
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
10.25
Today|||52-Week Range
41.00
-0.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues7.9M4.9M860.0K1.7M
 
 
 
 
 
Depreciation And Amortization11.0K9.0K6.0K6.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses39.2M24.2M13.2M12.2M
 
 
 
 
 
Research And Development21.0M15.4M8.5M4.4M
 
 
 
 
 
Total Operating Expenses39.2M24.2M13.2M12.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.3M-19.3M-12.3M-10.5M
 
 
 
 
 
Extraordinary Charge0.00-3.6M----
 
 
Interest Expense On Debt280.0K243.0K226.0K208.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.4M-22.9M-12.3M-10.4M
 
 
 
 
 
Net Income-31.4M-22.9M-12.3M-10.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.5M10.5M10.5M10.5M
 
 
 
 
 
Shares To Calculate EPS Diluted10.5M10.5M10.5M10.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.00-$2.20-$1.15-$1.00
 
 
 
 
 
EPS Diluted-$3.00-$2.20-$1.15-$1.00